LSMIP Editorial Office

Articles

Discussion on Digital Health

2023/03/09

Online Roundtable Discussion Among Clinical Doctors 【Part 6】

This issue will be the last “Sleep and Sleep Tech” online roundtable discussion with clinical doctors, attended by doctors interested in the current focus on “sleep tech.”　The topic will evolve into implementing apps in the medical field, cognitive behavioral therapy, and more.

Discussion on Digital Health

2022/12/29

Online Roundtable Discussion Among Clinical Doctors 【Part 5】

Continuing from the previous meeting, doctors interested in “Sleep Tech” will gather to discuss “Sleep and Sleep Tech” frankly. This time, they will discuss topics such as smart rings and mindfulness.

Discussion on Digital Health

2022/11/29

Online Roundtable Discussion Among Clinical Doctors 【Part 4】

Doctors interested in “Sleep Tech,” which has been the focus of much attention in recent years, were invited to gather to discuss “How does Sleep Tech work?” They will also talk about the effects and impressions of using it and ask each other about sleep-related topics. The content of this session is a casual read about “Sleep and Sleep Tech.” In this issue, we present the first of three roundtable discussions.

Discussion on Digital Health

2022/06/30

Online Roundtable Discussion Among Clinical Doctors 【Part 3】

This is the third and final part of the Online Roundtable Discussion Among Clinical Doctors on “About the Ongoing Application of Digital Technology in the Medical Field.” We will ask slightly different questions to doctors about their honest opinions about digital health.

Discussion on Digital Health

2022/04/28

Online Roundtable Discussion Among Clinical Doctors 【Part 2】

We are pleased to present the second part of the Online Roundtable Discussion Among Clinical Doctors, in which they share their views on the current state of digital health and what they expect in the future. This time, we asked questions about the content of the previous roundtable discussion. The following is a frank discussion by three clinical doctors on these questions.

Discussion on Digital Health

2022/02/22

Online Roundtable Discussion Among Clinical Doctors 【Part 1】

In recent years, digital transformation has been expected to advance in various fields, but how much digitalization is taking place in the medical field? How far has digitalization progressed in the medical field, and what are people in the medical field thinking about digital health? The topic of this meeting is “About the Ongoing Application of Digital Technology in the Medical Field.” The content of this roundtable will be divided into three parts.

Yakuji Nippo

2021/03/09

Requested for Preparation for Digitization of Package Inserts - GS1 Code Reading, etc.

On February 19, The Ministry of Health, Labor and Welfare (MHLW) issued a notice requesting marketing authorization holders to make...

Yakuji Nippo

2021/03/09

Publishing a list of drugs requiring stability protection-506 items such as Cefazolin

On February 26, the Ministry of Health, Labor and Welfare (MHLW) announced 506 items in its proposal about "Ensuring the...

Yakuji Nippo

2021/03/09

Issued Business Suspension Order to Nichi-Iko - Inappropriate Manufacturing at Toyama Plant 1

On March 3, Toyama Prefecture issued business suspension orders to Nichi-Iko for the issue of its manufacturing and sales of...

Yakuji Nippo

2021/02/18

Targeting Doubling of Bio-pharmaceutical Market - Specific Strategies for the Next 10 Years

On January 19, 2021, the government presented a draft of the "Bio-Strategy 2020 (Final version of Market Area Measures)" to ...

Yakuji Nippo

2021/02/18

Joint research between industry-academia-government to create new drugs-Building an integrated database of disease-specific information

Seven member companies of the Japan Pharmaceutical Manufacturers Association (JPMA) and the National Center Biobank Network (NCBN) announced on December...

Yakuji Nippo

2021/02/18

Technology strategies for practical use of biopharmaceuticals – Discussion at the review meeting in the next fiscal year

The Ministry of Economy, Trade and Industry (METI) will establish a "review meeting for life science technology strategies" to discuss...

Yakuji Nippo

2021/02/18

Business Suspension Order to Kobayashi Kako Co., Ltd for 116 Days - Longest Ever, For Keeping Quiet about Manufacturing Conditions

Data Fabrication and Dual Bookkeeping as Well Regarding the case of the health damage that occurred due to a sleep-inducing...

Yakuji Nippo

2021/01/22

Continuation of considering making online medical care permanent - to add these points to guidelines revision by the next fall.

The Ministry of Health, Labor and Welfare (MHLW) will continue to consider making online medical care permanent including the first ...

Yakuji Nippo

2021/01/22

Pharmaceutical Production Value Is 9.5 Trillion Yen - Saitama Prefecture Is Top Producer

The Ministry of Health, Labour and Welfare (MHLW) has released the "Annual Report on the Statistics of Production by Pharmaceutical ...

Yakuji Nippo

2020/12/29

280 generic products listed in National Health Insurance (NHI) Price List - Lyrica as the first generic drug and other drugs from 22 companies joined the list.

The Ministry of Health, Labor and Welfare (MHLW) will list 280 generic products in the price list of NHI today. The ...

Yakuji Nippo

2020/12/29

Ministers Agreed on Off-year Revision - Settled on Coverage of Deviation Rate of More than 5%, Prices to be Reduced for 70% of All Products

Minister of Finance Taro Aso, Chief Cabinet Secretary Katsunobu Kato and Minister of Health, Labor and Welfare Norihisa Tamura discussed ...

Yakuji Nippo

2020/12/22

Discontinues Development, Unable to Acquire Designation as Orphan Drugs – Demand for Designation Criteria Equivalent to Europe and U.S.

In the questionnaire investigation conducted on 59 member companies by the pharmaceutical affairs committee of the Japan Pharmaceutical Manufacturers Association, ...

Yakuji Nippo

2020/12/22

Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients

Life Data Initiative (LDI), NTT DATA Corporation, and Pfizer Inc. made an announcement on the December 14th that the three...

Yakuji Nippo

2020/12/18

Recurrence Prevention Measures for the SMA Drug Issue - Including Pre-evaluation of Application Data Committee on Regenerative Medicine Products and Biotechnology of Pharmaceutical Affairs and Food Sanitation Council

On December 3, 2020, the Committee on Regenerative Medicine Products and Biotechnology, Pharmaceutical Affairs and Food Sanitation Council generally approved ...

LSMIP Editorial Office

CM Plus Corporation

Articles

Online Roundtable Discussion Among Clinical Doctors 【Part 6】

Online Roundtable Discussion Among Clinical Doctors 【Part 5】

Online Roundtable Discussion Among Clinical Doctors 【Part 4】

Online Roundtable Discussion Among Clinical Doctors 【Part 3】

Online Roundtable Discussion Among Clinical Doctors 【Part 2】

Online Roundtable Discussion Among Clinical Doctors 【Part 1】

Requested for Preparation for Digitization of Package Inserts - GS1 Code Reading, etc.

Publishing a list of drugs requiring stability protection-506 items such as Cefazolin

Issued Business Suspension Order to Nichi-Iko - Inappropriate Manufacturing at Toyama Plant 1

Targeting Doubling of Bio-pharmaceutical Market - Specific Strategies for the Next 10 Years

Joint research between industry-academia-government to create new drugs-Building an integrated database of disease-specific information

Technology strategies for practical use of biopharmaceuticals – Discussion at the review meeting in the next fiscal year

Business Suspension Order to Kobayashi Kako Co., Ltd for 116 Days - Longest Ever, For Keeping Quiet about Manufacturing Conditions

Continuation of considering making online medical care permanent - to add these points to guidelines revision by the next fall.

Pharmaceutical Production Value Is 9.5 Trillion Yen - Saitama Prefecture Is Top Producer

280 generic products listed in National Health Insurance (NHI) Price List - Lyrica as the first generic drug and other drugs from 22 companies joined the list.

Ministers Agreed on Off-year Revision - Settled on Coverage of Deviation Rate of More than 5%, Prices to be Reduced for 70% of All Products

Discontinues Development, Unable to Acquire Designation as Orphan Drugs – Demand for Designation Criteria Equivalent to Europe and U.S.

Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients

Recurrence Prevention Measures for the SMA Drug Issue - Including Pre-evaluation of Application Data Committee on Regenerative Medicine Products and Biotechnology of Pharmaceutical Affairs and Food Sanitation Council

Digital Health
U.S. eHealth Journal

Most Popular

Interview with Dental Start-up SQRIE - About its Business Prospects

“Join”, a Communication App for Medical Professionals that　Enables to Share Medical Images Using Smartphones

The First Part: Tapping into the Challenges of Diabetes and Lifestyle Management, Health2Sync

Operation and Current Status of Apps for Eating Disorder Treatment

Aevice Health Develops Wearable Stethoscopes for Chronic Respiratory Disease Patients

Press Room

Placeholder

LSMIP Editorial Office

CM Plus Corporation

Articles

Online Roundtable Discussion Among Clinical Doctors 【Part 6】

Online Roundtable Discussion Among Clinical Doctors 【Part 5】

Online Roundtable Discussion Among Clinical Doctors 【Part 4】

Online Roundtable Discussion Among Clinical Doctors 【Part 3】

Online Roundtable Discussion Among Clinical Doctors 【Part 2】

Online Roundtable Discussion Among Clinical Doctors 【Part 1】

Requested for Preparation for Digitization of Package Inserts - GS1 Code Reading, etc.

Publishing a list of drugs requiring stability protection-506 items such as Cefazolin

Issued Business Suspension Order to Nichi-Iko - Inappropriate Manufacturing at Toyama Plant 1

Targeting Doubling of Bio-pharmaceutical Market - Specific Strategies for the Next 10 Years

Joint research between industry-academia-government to create new drugs-Building an integrated database of disease-specific information

Technology strategies for practical use of biopharmaceuticals – Discussion at the review meeting in the next fiscal year

Business Suspension Order to Kobayashi Kako Co., Ltd for 116 Days - Longest Ever, For Keeping Quiet about Manufacturing Conditions

Continuation of considering making online medical care permanent - to add these points to guidelines revision by the next fall.

Pharmaceutical Production Value Is 9.5 Trillion Yen - Saitama Prefecture Is Top Producer

280 generic products listed in National Health Insurance (NHI) Price List - Lyrica as the first generic drug and other drugs from 22 companies joined the list.

Ministers Agreed on Off-year Revision - Settled on Coverage of Deviation Rate of More than 5%, Prices to be Reduced for 70% of All Products

Discontinues Development, Unable to Acquire Designation as Orphan Drugs – Demand for Designation Criteria Equivalent to Europe and U.S.

Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients

Recurrence Prevention Measures for the SMA Drug Issue - Including Pre-evaluation of Application Data Committee on Regenerative Medicine Products and Biotechnology of Pharmaceutical Affairs and Food Sanitation Council

Digital HealthU.S. eHealth Journal

Most Popular

Interview with Dental Start-up SQRIE - About its Business Prospects

“Join”, a Communication App for Medical Professionals that Enables to Share Medical Images Using Smartphones

The First Part: Tapping into the Challenges of Diabetes and Lifestyle Management, Health2Sync

Operation and Current Status of Apps for Eating Disorder Treatment

Aevice Health Develops Wearable Stethoscopes for Chronic Respiratory Disease Patients

Press Room

Placeholder

Digital Health
U.S. eHealth Journal

“Join”, a Communication App for Medical Professionals that　Enables to Share Medical Images Using Smartphones